XERF · Radio Frequency Technology · Vaughan & the 905

Radio frequency technology, explained.

How controlled RF heat supports collagen remodeling—and what published research reports about monopolar RF and dual-frequency XERF for facial tightening.

Science-informed · Non-invasive · Consultation required

← Back to Tri-Health · XERF overview

The mechanism

Heat that asks collagen to rebuild.

Monopolar radiofrequency (RF) delivers electromagnetic energy into the skin. Tissue resistance converts that energy into controlled heat (Joule heating), which can immediately tighten existing collagen fibers and stimulate fibroblasts to produce new collagen over the following weeks to months.

Classic monopolar RF systems commonly use ~6.78 MHz. Research on dermal aging notes that fragmented and depleted collagen is a key driver of laxity—so modalities that remodel collagen are of particular interest for non-surgical tightening.

KEY IDEA

Immediate + delayed response

  • Immediate: heat-related collagen contraction / architectural change
  • Delayed: neocollagenesis and remodeling over weeks
  • Goal temperature band often discussed ~55–65°C in dermis with epidermal protection
  • Non-invasive contact delivery with surface cooling for comfort and safety

Why dual-frequency

XERF: two frequencies in one thoughtful pass.

XERF (Cynosure Lutronic) is a dual-frequency noninvasive monopolar RF platform that can deliver 6.78 MHz and 2 MHz energy—supporting treatment across more than one tissue depth in a single session strategy (shallow, middle, and deeper planes depending on settings).

01

Multi-depth intent

Dual frequencies are designed to influence superficial and deeper structural layers—not only the surface.

02

Comfort-focused delivery

Integrated cooling and pulsed delivery strategies are used to protect the epidermis and support tolerability without routine topical anesthesia in published protocols.

03

No needles, no downtime plan

Clinical reports describe noninvasive treatment with high satisfaction and no unexpected adverse events in studied cohorts.

Published findings · XERF / dual-frequency NMRF

What the studies report.

Below are publicly reported clinical findings. Individual results vary. These summaries are educational—not a guarantee of your outcome.

Prospective multicenter study (facial laxity / lower-face lifting). In 39 subjects completing two dual-frequency noninvasive monopolar RF sessions, clinician GAIS scores of ≥3 were achieved by 84.6% at 30 days and 92.3% at 90 days. Patient satisfaction (≥4/6) was 79.5% at 30 days and 84.6% at 90 days. No long-lasting adverse events were reported.
Source: Cureus prospective multicenter dual-frequency NMRF study (GAIS & satisfaction endpoints).
Korean clinical study — dual-frequency monopolar RF for facial photoaging (n=20). After a single treatment, blinded investigators correctly identified post-treatment photos in 80% of cases; mean GAIS improved significantly (reported ~2.75/4 range across evaluator reporting). All patients scored satisfaction ≥7/10. Pain was mild to moderate. No unexpected adverse events were recorded through 12-week follow-up.
Source: Hwang JK. J Korean Soc Laser Med. 2025 — dual-frequency NMRF photoaging study.
Retrospective evaluation of XERF (single-session dual-frequency NMRF). In 16 adult women with follow-up, objective imaging suggested volumetric redistribution (lateral volume increase / medial reduction patterns), progressive periorbital elevation metrics, and computerized skin-quality improvements (wrinkles, evenness, pores, oiliness) with no significant pigmentation change in that analysis. Subjective FACE-Q / satisfaction measures were reported as consistent with objective trends.
Source: Springer Medicine abstract — Objective and subjective retrospective evaluation of XERF.
Histologic / preclinical support for dual-frequency NMRF. Porcine histologic work on dual-frequency noninvasive monopolar RF has reported collagen-bundle thickening/shortening across dermal layers and fascial-layer responses not emphasized in older single-frequency narratives—supporting the depth-ranging rationale behind dual-frequency designs.
Sources: Hong et al., Skin Res Technol. 2024 (histologic evidence); Park et al., J Cosmet Dermatol. 2024 (porcine temperature/remodeling model).

Educational summary only. Study designs, sample sizes, and follow-up lengths vary. Tri-Health does not claim identical results for every patient. A consultation is required to assess candidacy.

Broader monopolar RF evidence

RF skin tightening has a longer clinical track record.

FIRMNESS

Measured firmness gains

A prospective facial monopolar RF series reported significant clinician-rated improvement in jowls/nasolabial folds by 12 weeks lasting to 24 weeks, with instrument-measured cheek firmness improving from 4 weeks through 24 weeks and no serious adverse events.

HISTOLOGY

Collagen architecture

In-vivo histometric analysis after monopolar RF showed increased collagen density/coherency in papillary and reticular dermis at follow-up timepoints—consistent with remodeling rather than surface-only change.

PREJUVENATION

Mechanism reviews

Recent laser/medicine reviews summarize monopolar RF as inducing immediate tightening plus delayed neocollagenesis, with emerging interest in repeated treatments for dermal “prejuvenation.”

Selected references: Kwon et al., Cosmetics 2024 (efficacy/safety with device metrics); Suh et al., J Cosmet Dermatol histometric analysis; Monopolar RF prejuvenation review in Lasers in Surgery and Medicine (2025 narrative review); randomized/controlled monopolar RF tightening comparisons reporting durable NLF volume changes to 6 months.

Citations

Sources

  1. Clinical Outcomes Following Dual-Frequency Noninvasive Monopolar Radiofrequency Treatment for Facial Laxity and Lower Face Lifting: A Prospective Multicenter Study. Cureus. DOI: 10.7759/cureus.104546
  2. Hwang JK. Evaluation of the clinical safety and efficacy of a noninvasive dual-frequency monopolar radiofrequency device in the treatment of facial photoaging sequelae in Republic of Korea. J Korean Soc Laser Med. 2025.
  3. Objective and subjective retrospective evaluation of XERF, a novel single-shot dual-frequency non-invasive monopolar radiofrequency. Springer Medicine abstract / Lasers Med Sci lineage.
  4. Hong J, et al. Efficacy of dual-frequency noninvasive monopolar radiofrequency in skin tightening: histological evidence. Skin Res Technol. 2024;30(6). doi:10.1111/srt.13821.
  5. Park C, et al. Monopolar radiofrequency for dermal temperature regulation and remodeling: a porcine model study. J Cosmet Dermatol. 2024.
  6. Kwon et al. Efficacy and Safety of Monopolar Radiofrequency for Tightening the Skin of Aged Faces. Cosmetics. 2024;11(3):71.
  7. Monopolar radiofrequency treatment for facial laxity: Histometric analysis. J Cosmet Dermatol.
  8. Monopolar Radiofrequency for Dermal Prejuvenation: Scientific Rationale and Mechanisms of Action. Lasers Surg Med. 2025.
  9. ClinicalTrials.gov: Safety and Efficacy Evaluation of the Xerf Device for Aesthetic Treatments (NCT07585591).

Always verify primary publications for full methods, conflicts, and limitations. Materials from manufacturer education folders may supplement—but peer-reviewed outcomes above are the citation backbone of this page.